CT-2106

DRUG2 trials

Sponsors

CTI BioPharma

Conditions

Colorectal CancerOvarian Cancer

Phase 1

Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

CompletedNCT00291785

CTI BioPharmaColorectal Cancer

Start: 2004-01-31End: 2008-09-30Updated: 2011-06-08

Phase 2

CT-2106 for the Second Line Treatment of Ovarian Cancer

CompletedNCT00291837

CTI BioPharmaOvarian Cancer

Start: 2004-11-30End: 2007-12-31Target: 40Updated: 2010-02-26